seekingalpha.com
/1 month ago
Latest updates for Tgtx
Fresh curated links around TGTX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- TG Therapeutics: Flawless Execution And $500 Million Non-Dilutive Capital Bolster Outlook
- MeiraGTx Holdings plc (MGTX) Discusses 3-Year Phase I Data on AAV-hAQP1 for Radiation-Induced Xerostomia and Commercial
- 10x Genomics, Inc. (TXG) Q1 2026 Earnings Call Transcript
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/1 month ago
MeiraGTx Holdings plc (MGTX) Discusses 3-Year Phase I Data on AAV-hAQP1 for Radiation-Induced Xerostomia and Commercial...
seekingalpha.com
/2 weeks ago
MeiraGTx Holdings plc (MGTX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
seekingalpha.com
/4 weeks ago
Telix Pharmaceuticals Limited (TLX) Discusses Advances in PSMA Therapy and Insights from the OPTIMAL-PSMA Trial with TLX...
explosiveoptions.net
/3 weeks ago
Travere Therapeutics Inc: Chart Analysis
Chart of the Week: Travere Therapeutics Hey good morning everyone. Time for our chart of the week for May 6. We’re gonna take a look at biotech name called Travere Therapeutics; TV...
seekingalpha.com
/1 week ago
Tango Therapeutics: 'Hold' On Combination Strategy Shift Of Vopimetostat
seekingalpha.com
/4 weeks ago
TPG RE Finance Trust, Inc. 2026 Q1 - Results - Earnings Call Presentation
seekingalpha.com
/2 weeks ago
Regenxbio: 'Hold' On RGX-121 CRL MPS II And RGX-202 DMD Results
pharmexec.com
/1 month ago
<![CDATA[Gilead Enters $5 Billion Agreement to Acquire Tubulis ]]>
biopharmadive.com
/1 month ago
Gilead continues M&A surge with $3.1B deal for ADC specialist Tubulis
Gilead’s third acquisition since late February hands it a technology designed to make antibody-drug conjugates less toxic and multiple cancer medicines already in clinical testing.
finance.yahoo.com
/1 month ago
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
seekingalpha.com
/1 month ago
Definium Therapeutics, Inc. (DFTX) Analyst/Investor Day - Slideshow
fool.com
/1 month ago
TRTX Q1 2026 Earnings Call Transcript
Image source: The Motley Fool. DATEApril 29, 2026 at 9 a.m. ETCALL PARTICIPANTSChief Executive Officer — Doug BouquardChief Financial Officer — Brandon FoxChief Operating Officer...
finance.yahoo.com
/1 month ago
Travere Therapeutics Inc. (TVTX): First-Mover Advantage Is Massive Moat
investing.com
/1 month ago
Taysha to present preclinical data on Rett syndrome gene therapy
pharmexec.com
/1 month ago
<![CDATA[Regeneron Enters $2.1 Billion Radiopharma Collaboration with Telix Pharmaceuticals ]]>
seekingalpha.com
/2 weeks ago
GCT Semiconductor Holding, Inc. (GCTS) Q1 2026 Earnings Call Transcript
cafepharma.com
/7 hours ago
Argenx
Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...
benzinga.com
/1 month ago
Telix Seeks Reset With FDA Filing While Sales Growth Holds Steady
FDA accepts Telix NDA for Pixclara for brain cancer imaging, analysts see confidence rebuild amid steady sales growth. Importance Rank: ...
finance.yahoo.com
/1 month ago
Here is Why Travere (TVTX) is an Overlooked Growth Stocks to Buy Now
finance.yahoo.com
/1 month ago
Here is Why Travere (TVTX) is an Overlooked Growth Stocks to Buy Now
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Tgtx
feeds.benzinga.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
explosiveoptions.net
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source